ÂÜÀòÂÒÂ×

The Leadership Team at the Structural Genomics Consortium is responsible for setting the strategic direction and overseeing the execution of initiatives that drive research in human biology and drug discovery. This diverse group of Chief Scientific Officers and financial leaders collaborates to foster partnerships with academic institutions and pharmaceutical companies, ensuring the organization remains at the forefront of open science and innovation in underexplored areas of the human genome. Their collective vision and guidance enable the SGC to maximize its impact on the global scientific community.